FY26 B1 foundation care pharm chemo NOV 25

Ended Awarded Last action

Contract number
15B40626F00000025
Awardee
Awarding agency
Obligated
$42,892

Award facts

Contract value 100% obligated
$42,891.81 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sand Lake, FL 32819, USA

Award details come from SAM.gov/FPDS.

About this award

Takeda Pharmaceuticals America, Inc. was awarded a delivery order by the Federal Correctional Complex Florence on October 1, 2025, valued at $42,891.81 for pharmaceutical chemotherapy foundation care products. This firm fixed-price delivery order, with an ultimate completion date of December 31, 2025, represents a child contract under Takeda's General Services Administration (GSA) Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract carries no small business set-aside designation, reflecting Takeda's status as a large, foreign-owned pharmaceutical manufacturer. The awarded products will be delivered to Orlando, Florida, supporting the federal correctional facility's healthcare operations.

Takeda Pharmaceuticals America, Inc., a Cambridge, Massachusetts-based subsidiary of Japan's Takeda Pharmaceutical Company Limited, is an established supplier of specialized pharmaceutical products to federal agencies. The company maintains two significant Indefinite Delivery Vehicles totaling approximately $3.0 billion in potential value, including a $2.9 billion Federal Supply Schedule contract and a $123.5 million Blanket Purchase Agreement focused on providing oncology medications to the Department of Veterans Affairs. While this particular delivery order is placed through the Federal Correctional Complex Florence rather than the VA, it reflects Takeda's broader role as a critical supplier of specialized pharmaceuticals to the federal government's healthcare systems.

Quick answers

Who was awarded contract 15B40626F00000025?

15B40626F00000025 was awarded to Takeda Pharmaceuticals America, Inc. by Federal Correctional Complex Florence (Correctional Facilities) on October 1, 2025.

How much is contract 15B40626F00000025 worth?

The government has obligated $42,892 on 15B40626F00000025.

Is contract 15B40626F00000025 an order under another contract?

Yes. 15B40626F00000025 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 15B40626F00000025 competed?

The extent of competition for 15B40626F00000025 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award